Rajyalakshmi Luthra

Personalized Medicine in a Phase I Clinical Trials Program: The MD Anderson Cancer Center Initiative

Apostolia M. Tsimberidou, Nancy G. Iskander, David S. Hong et al. · Clinical Cancer Research · 2012 · 528 citations · Full text

PI3K/AKT/mTOR Inhibitors in Patients With Breast and Gynecologic Malignancies Harboring <i>PIK3CA</i> Mutations

Filip Jankú, Jennifer J. Wheler, Shannon N. Westin et al. · Journal of Clinical Oncology · 2012 · 447 citations · Full text

Pegylated Interferon Alfa-2a Yields High Rates of Hematologic and Molecular Response in Patients With Advanced Essential Thrombocythemia and Polycythemia Vera

Alfonso Quintás‐Cardama, Hagop M. Kantarjian, Taghi Manshouri et al. · Journal of Clinical Oncology · 2009 · 412 citations · Full text

Hypoxia-regulated microRNA-210 modulates mitochondrial function and decreases ISCU and COX10 expression

Z. Chen, Yan Li, H. Zhang et al. · Oncogene · 2010 · 396 citations

Mitochondrial Biogenesis, Mitochondrial Function, Mitochondrial Dynamic +9

Frequency and clinical significance of BCR-ABL mutations in patients with chronic myeloid leukemia treated with imatinib mesylate

Elias Jabbour, Hagop M. Kantarjian, Dan Jones et al. · Leukemia · 2006 · 385 citations

Hematological Malignancy, Chronic Myeloid Leukemia, Health Sciences +9